Natural Beauty Bio-Technology Limited (NBBTF)
USD 0.06
(0.0%)
USD 0.06
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Operating Cash Flow | 2.07 Million | 1.06 Million | 5.48 Million | 3.88 Million | 2.6 Million |
| Net Income | -1.93 Million | -3.9 Million | 4.52 Million | 1 Million | 2.81 Million |
| Depreciation & Amortization | 3.41 Million | 4.39 Million | 4.48 Million | 4.8 Million | 3.96 Million |
| Deferred income taxes | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - |
| Change in working capital | 563.84 Thousand | -15.36 Thousand | -4.59 Million | -3.62 Million | -5.77 Million |
| Other non-cash items | 34.56 Thousand | 591.27 Thousand | 1.07 Million | 1.69 Million | 1.6 Million |
| Investing Cash Flow | -8.84 Million | -5.62 Million | -4 Million | -6.52 Million | -8.18 Million |
| Investments in PPE | -8.84 Million | -5.67 Million | -4.88 Million | -9.52 Million | -9.8 Million |
| Acquisitions | 128.03 | 42.11 Thousand | 1.04 Million | 2.58 Million | - |
| Investment purchases | - | - | -160.54 Thousand | 1.00 | - |
| Sales/Maturities of investments | - | - | -1.00 | 407.53 Thousand | 12.66 Million |
| Other Investing Activities | -0.03 | 1.00 | - | - | 3.54 Million |
| Financing Cash Flow | 6.35 Million | 2.31 Million | 1.83 Million | 3.84 Million | 2.59 Million |
| Debt repayment | -6.95 Million | -3.98 Million | -3.49 Million | -5 Million | -3.19 Million |
| Dividends payments | - | -6 Million | -6 Million | - | - |
| Common Stock Repurchased | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - |
| Other Financing Activities | 13.31 Million | 7.07 Million | 6.09 Million | 8.85 Million | -606.92 Thousand |
| Accounts receivables | 130.33 Thousand | 2.52 Million | 864.78 Thousand | 43.46 Thousand | -5.47 Million |
| Accounts payables | -2.06 Million | -2.97 Million | -2.12 Million | 1.63 Million | 1.32 Million |
| Inventory | 2.11 Million | -129.67 Thousand | -3.46 Million | -3.18 Million | -2.26 Million |
| Other working capital | 380.5 Thousand | 567.34 Thousand | 130.02 Thousand | -2.12 Million | 637.33 Thousand |
| Cash at beginning of period | 20.55 Million | 24.13 Million | 20.39 Million | 17.83 Million | 23.56 Million |
| Cash at end of period | 20.32 Million | 20.55 Million | 24.13 Million | 20.39 Million | 17.83 Million |
| Capital Expenditure | -8.84 Million | -5.67 Million | -4.88 Million | -9.52 Million | -9.8 Million |
| Effect of forex changes on cash | 1.4 Million | -9.87 Million | 4.06 Million | 9.65 Million | 0.22 |
| Net cash flow / Change in cash | -233.51 Thousand | -3.57 Million | 3.73 Million | 2.56 Million | -5.73 Million |
| Free Cash Flow | -6.77 Million | -4.6 Million | 598.57 Thousand | -5.64 Million | -7.19 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -1.94 Million | -1.94 Million | -365.3 Thousand | -1.93 Million | -364.26 Thousand | -600.17 Thousand |
| Depreciation & Amortization | 1.71 Million | - | 785.67 Thousand | 3.41 Million | 783.45 Thousand | 917.55 Thousand |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | - | 1.1 Million | 563.84 Thousand | 1.1 Million | - |
| Other non-cash items | 251.12 Thousand | 250.59 Thousand | -1.49 Million | 34.56 Thousand | -1.48 Million | 1.03 Million |
| Investing Cash Flow | -1.07 Million | -1.07 Million | 149.57 Thousand | -8.84 Million | 149.15 Thousand | -4.46 Million |
| Investments in PPE | -1.42 Million | -1.42 Million | -1.81 Million | -8.84 Million | -1.81 Million | -2.6 Million |
| Acquisitions | 15.23 Thousand | - | - | 128.03 | - | 127.57 |
| Investment purchases | - | - | 4.45 Million | - | - | -4.43 Million |
| Sales/Maturities of investments | 622.48 Thousand | - | -597 Thousand | - | - | 594.85 Thousand |
| Other Investing Activities | 353.69 Thousand | 352.95 Thousand | 1.96 Million | -0.03 | 1.95 Million | -1.86 Million |
| Financing Cash Flow | -741.77 Thousand | -740.21 Thousand | -133.95 Thousand | 6.35 Million | -133.57 Thousand | 2.85 Million |
| Debt repayment | -721.96 Thousand | - | -440.16 Thousand | -6.95 Million | - | -6.49 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -741.77 Thousand | -740.21 Thousand | -133.95 Thousand | 13.31 Million | -133.57 Thousand | 2.85 Million |
| Accounts receivables | - | - | 65.18 Thousand | 130.33 Thousand | 65 Thousand | - |
| Accounts payables | - | - | - | -2.06 Million | - | - |
| Inventory | - | - | 1.05 Million | 2.11 Million | 1.05 Million | - |
| Other working capital | - | - | -16.77 Thousand | 380.5 Thousand | -16.72 Thousand | - |
| Cash at beginning of period | 20.32 Million | - | 20.03 Million | 20.55 Million | - | 20.55 Million |
| Cash at end of period | -4.04 Million | -4.04 Million | 20.32 Million | 20.32 Million | 469.68 Thousand | 20.03 Million |
| Capital Expenditure | -1.42 Million | -1.42 Million | -1.81 Million | -8.84 Million | -1.81 Million | -2.6 Million |
| Effect of forex changes on cash | -534.06 Thousand | -532.93 Thousand | 422.16 Thousand | 1.4 Million | 420.96 Thousand | -330.97 Thousand |
| Net cash flow / Change in cash | -24.37 Million | -4.04 Million | 288.99 Thousand | -233.51 Thousand | 469.68 Thousand | -522.51 Thousand |
| Free Cash Flow | -3.12 Million | -3.12 Million | -1.78 Million | -6.77 Million | -1.77 Million | -1.24 Million |
RIBS
047040
1TY
2347
CCCMF
300322